Ellipsis Health
Ellipsis Health is a pioneering company focused on automating care management through its patented voice biomarker technology. By leveraging peer-reviewed science, the company enables healthcare partners to enhance patient and provider experiences, streamline workflows, and significantly reduce care costs. With over 2 million labeled minutes of speech analyzed, Ellipsis Health is positioned to transform mental health care by prioritizing it alongside physical health, thus creating a comprehensive approach to whole person care. Their innovative solutions have led to a 50% reduction in administrative tasks, showcasing their traction and effectiveness in the healthcare market.
Ellipsis Health
Ellipsis Health is a pioneering company focused on automating care management through its patented voice biomarker technology. By leveraging peer-reviewed science, the company enables healthcare partners to enhance patient and provider experiences, streamline workflows, and significantly reduce care costs. With over 2 million labeled minutes of speech analyzed, Ellipsis Health is positioned to transform mental health care by prioritizing it alongside physical health, thus creating a comprehensive approach to whole person care. Their innovative solutions have led to a 50% reduction in administrative tasks, showcasing their traction and effectiveness in the healthcare market.
TL;DR
Founded: November 2017
Headquarters: San Francisco, California
Core product: Voice-based vocal biomarker technology and empathetic AI Care Manager (Sage)
Employee count: 58
Latest funding: $45M Series A (Jun 12, 2025)
Company Overview
Problem Domain
Behavioral health detection and care management; clinical workflow automation.
Founded
2017
Industry
Artificial Intelligence in health care / Health IT
Funding Track Record
$45,000,000
Round announced to scale Sage, the AI Care Manager; included participation from Mitsui Global Investment, Collier, E12 Ventures, and AME Cloud Ventures per company release.
Investor Signal
“Backed by strategic and venture investors including Salesforce (Marc Benioff), Khosla Ventures, and CVS Health Ventures”